SPMV:PA:PA-Ossiam US Minimum Variance ESG NR UCITS ETF 1A (EUR) (EUR)

ETF | Others |

Last Closing

USD 240

Change

0.00 (0.00)%

Market Cap

USD 0.05B

Volume

9.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
WRD:PA HSBC ETFs Public Limited Compa..

+0.55 (+1.79%)

USD 9.26B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+9.55 (+2.04%)

USD 8.86B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.53 (+1.10%)

USD 7.39B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+11.60 (+2.95%)

USD 6.76B
HHH:PA HSBC ETFs Public Limited Compa..

+0.97 (+2.06%)

USD 6.63B
WLD:PA Lyxor UCITS MSCI World D-EUR

+5.61 (+1.84%)

USD 6.20B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.30 (+1.85%)

USD 4.86B
WSRI:PA Amundi MSCI World SRI Climate ..

+1.45 (+1.62%)

USD 4.32B
500U:PA Amundi Index Solutions - Amund..

+1.65 (+1.69%)

USD 4.28B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+3.21 (+2.40%)

USD 3.71B

ETFs Containing SPMV:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 28.10% 46% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.10% 46% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 4.79% 54% F 56% F
Dividend Return 4.79% 77% C+ 51% F
Total Return N/A 100% F 100% F
Risk Return Profile  
Volatility (Standard Deviation) 10.88% 63% D 80% B-
Risk Adjusted Return 43.99% 53% F 67% D+
Market Capitalization 0.05B 21% F 33% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.